These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37016517)

  • 1. Prevalence and Associated Factors of Toenail Onychomycosis Among Patients with Diabetes in Jordan.
    Alrauosh H; Ababneh A; Bakri FG; Abujbara M; Kanaan H; Younes NA
    Curr Diabetes Rev; 2024; 20(1):e030423215425. PubMed ID: 37016517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, Risk Factors, and Type of Organism in Fungal Foot Infection and Toenail Onychomycosis in Thai Diabetic Patients.
    Assadamongkol R; Lertwattanarak R; Wannachalee T; Bunyaratavej S; Leeyaphan C; Matthapan L
    J Med Assoc Thai; 2016 Jun; 99(6):659-64. PubMed ID: 29900728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns.
    Eba M; Njunda AL; Mouliom RN; Kwenti ET; Fuh AN; Nchanji GT; Atashili J
    BMC Res Notes; 2016 Nov; 9(1):494. PubMed ID: 27876085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial.
    Farkas B; Paul C; Dobozy A; Hunyadi J; Horváth A; Fekete G
    Br J Dermatol; 2002 Feb; 146(2):254-60. PubMed ID: 11903236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of toenail onychomycosis in patients with type 2 diabetes mellitus and evaluation of risk factors.
    Gulcan A; Gulcan E; Oksuz S; Sahin I; Kaya D
    J Am Podiatr Med Assoc; 2011; 101(1):49-54. PubMed ID: 21242470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with presence and severity of toenail onychomycosis in patients with diabetes: a cross-sectional study.
    Takehara K; Oe M; Tsunemi Y; Nagase T; Ohashi Y; Iizaka S; Ueki K; Tsukamoto K; Kadowaki T; Sanada H
    Int J Nurs Stud; 2011 Sep; 48(9):1101-8. PubMed ID: 21367414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Associates of Foot Deformities among Patients with Diabetes in Jordan.
    Ababneh A; Bakri FG; Khader Y; Lazzarini P; Ajlouni K
    Curr Diabetes Rev; 2020; 16(5):471-482. PubMed ID: 31573891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of toenail onychomycosis among diabetics at a primary care facility in Malaysia.
    Leelavathi M; Azimah MN; Kharuddin NF; Tzar MN
    Southeast Asian J Trop Med Public Health; 2013 May; 44(3):479-83. PubMed ID: 24050080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onychomycosis is associated with subclinical atherosclerosis in patients with diabetes.
    Onalan O; Adar A; Keles H; Ertugrul G; Ozkan N; Aktas H; Karakaya E
    Vasa; 2015 Jan; 44(1):59-64. PubMed ID: 25537059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey.
    Gupta AK; Konnikov N; MacDonald P; Rich P; Rodger NW; Edmonds MW; McManus R; Summerbell RC
    Br J Dermatol; 1998 Oct; 139(4):665-71. PubMed ID: 9892911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toenail onychomycosis in diabetic patients: issues and management.
    Mayser P; Freund V; Budihardja D
    Am J Clin Dermatol; 2009; 10(4):211-20. PubMed ID: 19489654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients.
    Kuvandik G; Cetin M; Genctoy G; Horoz M; Duru M; Akcali C; Satar S; Kiykim AA; Kaya H
    BMC Infect Dis; 2007 Aug; 7():102. PubMed ID: 17760994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toenail onychomycosis: an important global disease burden.
    Thomas J; Jacobson GA; Narkowicz CK; Peterson GM; Burnet H; Sharpe C
    J Clin Pharm Ther; 2010 Oct; 35(5):497-519. PubMed ID: 20831675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onychomycosis in patients with chronic leg ulcer and toenail abnormalities.
    Cabete J; Galhardas C; Apetato M; Lestre S
    An Bras Dermatol; 2015; 90(1):136-9. PubMed ID: 25672317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of diabetic peripheral neuropathy among diabetic Palestinian refugees in the Nuzha area, Jordan: a cross-sectional study.
    Atallah SM; Al-Jaghbir MT; Zayed AA
    Lancet; 2021 Jul; 398 Suppl 1():S15. PubMed ID: 34227946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Population-based study of Toenail onychomycosis in Israeli children.
    Leibovici V; Evron R; Dunchin M; Westerman M; Ingber A
    Pediatr Dermatol; 2009; 26(1):95-7. PubMed ID: 19250420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations.
    Gupta AK; Daigle D; Foley KA
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1039-44. PubMed ID: 25413984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifth toenail clinical response to systemic antifungal therapy is not a marker of successful therapy for other toenails with onychomycosis.
    Avner S; Nir N; Henri T
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1194-6. PubMed ID: 17062030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onychomycosis and Tinea Pedis in the Feet of Patients With Diabetes.
    Aragón-Sánchez J; López-Valverde ME; Víquez-Molina G; Milagro-Beamonte A; Torres-Sopena L
    Int J Low Extrem Wounds; 2023 Jun; 22(2):321-327. PubMed ID: 33891512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.